Polar Asset Management Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,900
| Closed | -$211K | – | 726 |
|
|
2024
Q2 | $211K | Sell |
3,900
-88,400
| -96% | -$4.79M | ﹤0.01% | 430 |
|
|
2024
Q1 | $6.47M | Buy |
+92,300
| New | +$6.47M | 0.11% | 143 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 795 |
|
|
2023
Q3 | – | Sell |
-190,400
| Closed | -$6.21M | – | 878 |
|
|
2023
Q2 | $6.21M | Buy |
+190,400
| New | +$6.21M | 0.11% | 220 |
|
|
2022
Q2 | – | Sell |
-82,600
| Closed | -$3.04M | – | 1329 |
|
|
2022
Q1 | $3.04M | Hold |
82,600
| – | – | 0.03% | 515 |
|
|
2021
Q4 | $3.77M | Buy |
82,600
+26,900
| +48% | +$1.23M | 0.04% | 450 |
|
|
2021
Q3 | $1.99M | Sell |
55,700
-116,400
| -68% | -$4.16M | 0.02% | 502 |
|
|
2021
Q2 | $3.41M | Buy |
+172,100
| New | +$3.41M | 0.03% | 437 |
|